Article 6T3ZC The World’s First Crispr Drug Gets a Slow Start

The World’s First Crispr Drug Gets a Slow Start

by
Emily Mullin
from on (#6T3ZC)
Story ImageThe first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.
External Content
Source RSS or Atom Feed
Feed Location http://feeds.wired.com/wired/index
Feed Title
Feed Link http://feeds.wired.com/
Reply 0 comments